b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30827526</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>15</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1556-5653</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>111</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>03</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Fertility and sterility</Title>\n                <ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>579-587.e1</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0015-0282(18)32229-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2018.11.034</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">To assess the association of insulin resistance markers, body mass index (BMI), age, and androgen levels with systemic arterial hypertension (SAH) defined according to 2017 American College of Cardiology/American Heart Association (ACC/AHA) criteria in polycystic ovary syndrome (PCOS); and to determine the risk of metabolic abnormalities in the presence of SAH defined by both the 2017 ACC/AHA and Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) criteria in women with PCOS.</AbstractText>\n                <AbstractText Label="DESIGN">Cross-sectional study.</AbstractText>\n                <AbstractText Label="SETTING">Research center.</AbstractText>\n                <AbstractText Label="PATIENT(S)">Biobanked samples obtained from 233 women with PCOS and 70 controls without hirsute, ovulatory dysfunction.</AbstractText>\n                <AbstractText Label="INTERVENTION(S)">Metabolic, hormonal, and biochemical assessment.</AbstractText>\n                <AbstractText Label="MAIN OUTCOME MEASURE(S)">Blood pressure status according to 2017 ACC/AHA and JNC7 criteria and prevalence of metabolic abnormalities.</AbstractText>\n                <AbstractText Label="RESULT(S)">The prevalence of SAH among women with PCOS was 65% (n = 152) using 2017 ACC/AHA criteria and 26.6% (n = 62) considering JNC7 criteria. The 90 women whose SAH status was changed by 2017 ACC/AHA criteria were categorized as stage 1 SAH (systolic blood pressure 130-139\xc2\xa0mmHg and/or diastolic blood pressure 80-89\xc2\xa0mmHg), requiring nonpharmacologic therapy only (lifestyle changes). The prevalence of SAH in the control group was 41.4% (n = 29) according to 2017 ACC/AHA criteria and 12.8% (n = 9) according to JNC7 criteria. In all groups, SAH was associated with higher homeostasis model assessment and insulin levels compared with normal blood pressure (P&lt;.01). In women with PCOS, the risk ratio for glucose \xe2\x89\xa5100\xc2\xa0mg/dL (prevalence ratio 3.88, 95% confidence interval [CI] 1.30-11.55), high-density lipoprotein (HDL) &lt;50\xc2\xa0mg/dL (prevalence ratio 2.13, 95% CI 1.45-3.12), and triglycerides \xe2\x89\xa5150\xc2\xa0mg/dL (prevalence ratio 3.39, 95% CI 1.56-7.35) was higher with SAH versus normal blood pressure when 2017 ACC/AHA criteria were applied, and did not increase or increased slightly when JNC7 criteria were applied (glucose \xe2\x89\xa5100\xc2\xa0mg/dL, prevalence ratio 1.38, 95% CI 0.99-1.91), HDL &lt;50\xc2\xa0mg/dL (prevalence ratio 1.1, 95% CI 0.99-1.37), and triglycerides \xe2\x89\xa5150\xc2\xa0mg/dL (prevalence ratio 1.48, 95% CI 1.13-1.94).</AbstractText>\n                <AbstractText Label="CONCLUSION(S)">The risk of cardiometabolic co-morbidities was increased in women with SAH defined by 2017 ACC/AHA criteria. Lower cutoffs for abnormal blood pressure seem appropriate for women with PCOS, providing a simple screening tool for cardiometabolic co-morbidities and an opportunity for early primary prevention.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Marchesan</LastName>\n                    <ForeName>Lucas Bandeira</ForeName>\n                    <Initials>LB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Gynecologic Endocrinology Unit, Division of Endocrinology, Hospital de Cl\xc3\xadnicas de Porto Alegre (HCPA), Porto Alegre, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Spritzer</LastName>\n                    <ForeName>Poli Mara</ForeName>\n                    <Initials>PM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Gynecologic Endocrinology Unit, Division of Endocrinology, Hospital de Cl\xc3\xadnicas de Porto Alegre (HCPA), Porto Alegre, Brazil; Laboratory of Molecular Endocrinology, Department of Physiology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. Electronic address: spritzer@ufrgs.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Fertil Steril</MedlineTA>\n            <NlmUniqueID>0372772</NlmUniqueID>\n            <ISSNLinking>0015-0282</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008055">Lipids</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000631407">SHBG protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D012738">Sex Hormone-Binding Globulin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>3XMK78S47O</RegistryNumber>\n                <NameOfSubstance UI="D013739">Testosterone</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>Fertil Steril. 2019 Mar;111(3):471-472</RefSource>\n                <PMID Version="1">30827520</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000572" MajorTopicYN="N">American Heart Association</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D062186" MajorTopicYN="Y">Arterial Pressure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011085" MajorTopicYN="N">Polycystic Ovary Syndrome</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012738" MajorTopicYN="N">Sex Hormone-Binding Globulin</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Hypertension</Keyword>\n            <Keyword MajorTopicYN="Y">androgen</Keyword>\n            <Keyword MajorTopicYN="Y">cardiovascular diseases</Keyword>\n            <Keyword MajorTopicYN="Y">insulin resistance</Keyword>\n            <Keyword MajorTopicYN="Y">polycystic ovary syndrome</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30827526</ArticleId>\n            <ArticleId IdType="pii">S0015-0282(18)32229-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.fertnstert.2018.11.034</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'